DDIT4 and breast carcinoma: We also found that the overexpression of DDIT4 was significantly correlated with different tumor stages, patient age, primary subtypes, major subclasses with TNBC, nodal metastasis status, and TP53 mutation status (Fig. 6), indicating a strong correlation between DDIT4 overexpression and breast cancer progression.